How ITS Cut Manual Safety Tracking by 60% and Strengthened PV Oversight Across Clinical Trials

July 15, 2026

How ITS Cut Manual Safety Tracking by 60% and Strengthened PV Oversight Across Clinical Trials

About Integrated Therapeutic Solutions

Integrated Therapeutic Solutions (ITS) is a clinical research organization conducting multi-country clinical trials and supporting post-marketing needs across a growing sponsor portfolio. As case volumes increased, so did the complexity of managing pharmacovigilance activities from safety event intake and workflow tracking to regulatory reporting and cross-functional coordination with clinical operations teams.

ITS implemented Flex Databases Pharmacovigilance to bring structure, consistency, and oversight to these activities. The impact was significant and measurable.

Pharmacovigilance in Clinical Trials: The Stakes Are High

In clinical research, pharmacovigilance is not a background function – it is a regulatory and ethical obligation. Safety events must be captured, assessed, tracked, and reported within strict timelines. Failures in PV workflow management carry direct consequences: delayed submissions, regulatory findings, and compromised patient safety oversight.

 For a CRO like ITS, PV operational quality is also a commercial signal. Sponsors evaluate CROs not just on study delivery, but on the rigor and transparency of their safety operations.

The Challenge: Manual Processes, Fragmented Oversight

Before implementing Flex Databases, ITS managed pharmacovigilance activities through a combination of manual tracking tools, email-based communication, and disconnected systems. As the study portfolio grew, these approaches created compounding operational risk:

  • Safety workflows tracked manually, with no systematic status visibility
  • No centralized view of outstanding actions or approaching reporting deadlines
  • Limited coordination between PV and clinical operations teams
  • Time-consuming retrieval of safety documentation and reporting history
  • Inconsistent processes across different studies and therapeutic areas
  • Administrative burden that grew faster than headcount

The result was a PV function that worked hard but lacked the infrastructure to scale without increasing risk.

The Solution: Flex Databases Pharmacovigilance

ITS deployed Flex Databases Pharmacovigilance as its centralized safety management platform, integrated with clinical operations and quality teams. The implementation focused on the areas where manual processes created the most risk and inefficiency:

  • Structured safety event intake, triage, and workflow routing
  • Automated status tracking and deadline notifications
  • Centralized repository for safety documentation and reporting history
  • Cross-functional dashboards visible to both PV and clinical operations teams
  • Role-based access controls and complete audit trails across all activities

The platform gave ITS’s PV team a single, structured environment to manage safety workflows – replacing fragmented manual processes with a system designed specifically for the demands of clinical trial pharmacovigilance.

Results at a Glance

60% Reduction in manual safety status tracking45% Improvement in safety workflow tracking efficiency
  
Faster Access to safety documentation & reporting historyUnified Cross-functional PV ↔ clinical ops visibility

Detailed Results

Workflow Efficiency

The most immediate impact of Flex Databases was the reduction in manual safety tracking work. Activities that previously required staff to chase status updates, reconcile spreadsheets, and coordinate by email were replaced by structured, system-driven workflows:

AreaResult
Manual safety status tracking activities60% reduction
Safety workflow tracking efficiency45% improvement
Time to access safety documentationSignificantly faster
Safety reporting history retrievalOn-demand, centralized

The PV team’s capacity effectively increased without adding headcount – staff time shifted from administrative tracking to substantive safety oversight work.

Cross-Functional Visibility

One of the most operationally significant outcomes was the improvement in coordination between the PV team and clinical operations. In a CRO environment, safety events often have downstream implications for study timelines, protocol deviations, and sponsor communications. When PV and clinical operations work from disconnected systems, these connections are managed informally – creating gaps and delays.

 Flex Databases gave both teams a shared operational picture. Safety workflow status, outstanding actions, and documentation were visible across functions — enabling faster, more coordinated responses to safety events.

This cross-functional visibility also strengthened ITS’s ability to provide sponsors with accurate, timely safety updates an increasingly important factor in sponsor satisfaction and CRO selection.

Compliance and Oversight

Clinical trial PV operates under strict regulatory frameworks. Complete audit trails, documented decision-making, and timely reporting are not optional – they are inspectable requirements. Flex Databases provided ITS with the traceability infrastructure to meet these obligations consistently:

AreaResult
Audit trail coverage across safety workflowsComplete, system-generated
Safety documentation accessibility during auditsImmediate, centralized
Process consistency across studiesStandardized via platform workflows
Regulatory reporting traceabilityFull history, on demand
ITS“Flex Databases helped us bring real structure to our PV workflows. Manual tracking dropped significantly, our teams had much better visibility into safety activities, and coordination with clinical operations became far more effective. It gave us the operational foundation to manage PV properly as our study portfolio grows.”

Looking Ahead: Scaling Into Post-Marketing PV

The clinical trial PV infrastructure behind these results reflects a broader, long-standing commitment to pharmacovigilance across the full drug development lifecycle. For nearly a decade, ITS has been supporting the post-marketing safety needs of key drug programs in the US – managing safety intake, regulatory maintenance, and case processing with the same operational rigor applied to its clinical trial portfolio. This established foundation gives ITS the capacity to take on a significantly higher volume of safety cases with efficiency and confidence in quality, supporting clients across the full product lifecycle and adhering to the rigid reporting timelines that post-marketing safety demands.

Flex Databases Pharmacovigilance supports this work with ICH E6(R3)-compliant safety reporting infrastructure, including direct regulatory submission pathways to agencies such as the FDA – providing the compliance-grade traceability and audit trail depth that post-marketing safety requires.

Together, ITS’s decade-long post-marketing track record and its structured, scalable platform infrastructure position it as a full-service PV partner – established in both pre- and post-marketing drug safety, and built to scale with the growing demands of its sponsor portfolio.

Conclusion

Pharmacovigilance is one of the highest-stakes functions in clinical research. The consequences of process failures are missed deadlines, incomplete documentation, fragmented oversight – extend beyond operational inefficiency to regulatory exposure and patient safety risk.

ITS addressed this by building its PV operations on Flex Databases Pharmacovigilance. The results – a 60% reduction in manual tracking, significantly improved workflow efficiency, and unified cross-functional visibility – reflect what happens when a CRO invests in purpose-built infrastructure for safety management.

For sponsors evaluating CRO partners, ITS’s PV capability and the platform behind it is a concrete indicator of operational maturity and regulatory readiness.

Blog

How ITS Cut Manual Safety Tracking by 60% and Strengthened PV Oversight Across Clinical Trials

About Integrated Therapeutic Solutions Integrated Therapeutic Solutions (ITS) is a clinical research organization conducting multi-country clinical trials and supporting post-marketing needs across a growing sponsor portfolio. As case volumes increased, so did the complexity of managing pharmacovigilance activities from safety event intake and workflow tracking to regulatory reporting and cross-functional coordination with clinical operations teams. […]

July 7, 2026
Is Your EDC Really Modern If Someone Still Has to Re-Enter Every Serious Adverse Event?

Clinical industry has finally embraced AI, sponsors run decentralized trials and data is now collected in real time. But still one of the most critical workflows in every study – handling adverse events (AEs) – surprisingly depends on copy-paste. Most sponsors assume that if they have an Electronic Data Capture (EDC) system and a Pharmacovigilance […]

June 30, 2026
Validating AI in GxP Environments: The Flex Databases Approach to eTMF Compliance

The pharmaceutical industry faces a familiar paradox: the tools that promise to make regulatory compliance faster and smarter also introduce the most complex new compliance questions. Nowhere is this more visible than in AI-powered Trial Master File (TMF) management. At Flex Databases, we have developed a validation framework rooted in GxP principles, risk-based thinking, and […]

June 25, 2026
The Quiet Revolution in TMF: How AI Document Classification Turns Routine into a Background Task

AI in Trial Master File management has quietly stopped being a someday idea. It’s not a pilot and it’s not a roadmap promise – it’s something clinical teams reach for on an ordinary Tuesday. The interesting part isn’t that AI can file a document; it’s how calmly and predictably it does it now – with […]

Contact us

Get in touch to discuss compliance, implementation, demos, pricing

We are here for all of your questions! Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.